Patents by Inventor Vaijnath Aravat

Vaijnath Aravat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8404727
    Abstract: The present patent application relates to a pharmaceutical composition for oral administration that includes a certain pyrrolidine derivative as DPP-IV inhibitor, and a pharmaceutically acceptable excipient. More particularly, the present invention contemplates pharmaceutical compositions that include melogliptin and a pharmaceutically acceptable excipient as well as to processes for preparing the pharmaceutical composition and the use of the composition in reducing glucose level in a subject. The present invention also contemplates an impurity associated with melogliptin.
    Type: Grant
    Filed: January 7, 2010
    Date of Patent: March 26, 2013
    Assignee: Glenmark Pharmaceuticals S.A.
    Inventors: Ulhas Dhuppad, Vaijnath Aravat, Someshwar Navhat, Abraham Thomas, Suresh Kadam
  • Publication number: 20100173964
    Abstract: The present patent application relates to a pharmaceutical composition for oral administration that includes a certain pyrrolidine derivative as DPP-IV inhibitor, and a pharmaceutically acceptable excipient. More particularly, the present invention contemplates pharmaceutical compositions that include melogliptin and a pharmaceutically acceptable excipient as well as to processes for preparing the pharmaceutical composition and the use of the composition in reducing glucose level in a subject. The present invention also contemplates an impurity associated with melogliptin.
    Type: Application
    Filed: January 7, 2010
    Publication date: July 8, 2010
    Applicant: Glenmark Pharmaceuticals S.A.
    Inventors: Ulhas DHUPPAD, Vaijnath Aravat, Someshwar Navhat, Abraham Thomas, Suresh Kadam